Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Central Retinal Vein Occlusion Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 82
Abbreviations 82
Definitions 82
Research Methodology 83
Secondary Research 83
About GlobalData 84
Contact Us 84
Source 84
List of Tables
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2017* 6
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2017* 14
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2017* 17
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2017* 19
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
List of Figures
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2017* 14
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2017* 17
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
GlobalData Methodology 83
